What Can We Expect From Abbott’s Q1’16 Earnings?
Leading healthcare major, Abbott Laboratories is set to announce its Q1 2016 results on April 20, 2016. A stronger U.S dollar (relative to emerging markets currencies) and a challenging economic environment in Venezuela had together weighed down Abbott’s profitability in Q4’15. We expect the currency effects to continue to impact its profitability throughout 2016. The company’s management had guided a 10% negative impact due to currency effects for 2016 in the previous quarter results. Earlier this quarter, Abbott acquired Alere, a company that should help it gain leadership in point-of-care diagnostics going ahead. Furthermore, we believe that the company’s strong fundamentals will gradually be reflected in its top-line growth when the currency headwinds start to ease. Below we take a look at the key financial metrics as expected for Abbott in Q1’16:
See the links below for more information and analysis about Abbott:
- What is Abbott’s Revenue And Gross Profit Breakdown?
- By What Percentage Did Abbott’s Revenue & Gross Profits Grow In The Last 5 Years?
- What’s Next For Abbott Stock After A 6% Rise This Year?
- Is Abbott Stock Undervalued At $95?
- Which Is A Better Pick – Abbott Stock Or Amgen?
- Is Abbott Stock A Better Healthcare Pick Over Thermo Fisher Scientific?
- Lower Testing Demand To Weigh On Abbott’s Q2?
- Will Abbott Stock Rebound To Its 2022 Highs?
Notes: